Update on FDA-Related Qui Tams and the False Claims Act (FCA)

On Dec. 7, Hamsa Mahendranathan appeared on a panel titled “Update on FDA-Related Qui Tams and the False Claims Act (FCA)” at the Food and Drug Law Institute’s Enforcement, Litigation, and Compliance Conference in Washington, D.C.